Condition (MeSH)
Cryoglobulinemia
ClinicalTrials.gov lists 10 trials for Cryoglobulinemia or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
10 of the 10 trials are tagged with Cryoglobulinemia itself; the rest are tagged with a narrower condition beneath it.
When did Cryoglobulinemia trials start? (8)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1/2
- Phase 2
- Phase 2/3
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2021 | 2 |
| 2018 | 1 |
| 2016 | 2 |
| 2015 | 1 |
| 2013 | 1 |
| 2009 | 1 |
| 2008 | 1 |
| 2001 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Cryoglobulinemia trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 1 |
| Phase 2 | 3 |
| Phase 2/3 | 1 |
| Observational | 5 |
How many Cryoglobulinemia trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 2 |
| Completed | 4 |
| Terminated | 1 |
| Unknown status | 3 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Cryoglobulinemia trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| French National Agency for Research on AIDS and Viral Hepatitis | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
Which drugs are being tested for Cryoglobulinemia? (3)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| RITUXIMAB | 3 |
| Belimumab | 1 |
| Prednisone | 1 |
Interventions as named in the registry (4)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| new antiviral therapy | 1 |
| Low-dose Aldesleukin (Proleukin®) | 1 |
| Epclusa | 1 |
| Harvoni | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Cryoglobulinemia trials report? (5)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| AST elevation > grade 3 | 6 | 1 |
| Infection | 3 | 1 |
| Leukopenia | 3 | 1 |
| thrombocytopenia | 2 | 1 |
| Herpes Zoster | 1 | 1 |
Which publications cover Cryoglobulinemia? (38)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Purtscher-like Retinopathy as a Rare Presentation of Cryoglobulinemia. | Middle East African journal of ophthalmology | 2016 | Yes |
| Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study. | Hepatology (Baltimore, Md.) | 2015 | Yes |
| Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24. | Annals of the rheumatic diseases | 2014 | Yes |
| The diagnosis and classification of the cryoglobulinemic syndrome. | Autoimmunity reviews | 2014 | Yes |
| Assessment of total hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia. | Arthritis research & therapy | 2014 | Yes |
Showing 5 of 38 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.